Results 141 to 150 of about 996 (195)

Head and Neck Malignancies in Autoimmune Polyendocrine Syndrome Type 1 (APS-1/APECED): A Scoping Review of Molecular Pathogenesis, Clinical Features, and Outcomes. [PDF]

Int J Mol Sci
Tarle M, Raguž M, Lukšić I.
europepmc   +1 more source

Clinical impact of inappropriate DOAC dosing in atrial fibrillation: Insights from a real-world registry. [PDF]

Int J Cardiol Heart Vasc
Yildirim M, Hund H, Mueller-Hennessen M, Katus HA, Frey N, Giannitsis E, Salbach C.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ketoconazole induced papilledema

Acta Ophthalmologica, 1993
Abstract Ketoconazole was administered in a case of hirsutismus over a period of 4 months with high doses of 800 mg/day, and bilateral papilledema developed. After cessation of the drug the condition disappeared. As far as we know this is the first reported papilledema complication due to Ketoconazole.
AKBATUR, H, BILGIHAN, K, CAKIR, N, HASANERISOGLU, B, OR, M   +4 more
openaire   +3 more sources

Ketoconazole and the Antifungals

Otolaryngology–Head and Neck Surgery, 1985
A new antifungal agent, ketoconazole, has been added to the drugs available for the treatment of fungal infections. Ketoconazole has been shown to be effective in the treatment of mucocutaneous candidiasis with a reported 97% positive response rate. This drug may be administered orally to outpatients with a low risk of toxicity.
openaire   +2 more sources

Ketoconazole

Medical Journal of Australia, 1983
  +5 more sources

Ketoconazole Effects

Annals of Internal Medicine, 1982
D A, Stevens, P L, William, A M, Sugar, A, Pont   +3 more
openaire   +2 more sources

KETOCONAZOLE AND THE LIVER

The Lancet, 1982
C R, Horseburgh, C H, Kirkpatrick, C B, Teutsch   +2 more
openaire   +2 more sources

KETOCONAZOLE AND CYCLOSPORIN

The Lancet, 1982
H, Dieperink, J, Møller
openaire   +2 more sources